세계의 신경용 색전 기기 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Embolization Devices For Neurology Market is presumed to reach the market size of nearly USD 2.14 Billion by 2032 from USD 1.55 Billion in 2023 with a CAGR of 3.62% under the study period 2024-2032.

Embolization devices for neurology are specialized medical instruments used to treat neurological conditions by occluding or blocking blood vessels in the brain. These devices are employed in procedures such as endovascular embolization to manage conditions like brain aneurysms, arteriovenous malformations, and tumors. Common embolization devices include coils, plugs, and liquid embolic agents, designed to induce clotting and permanently obstruct blood flow to targeted areas. By reducing or stopping the blood supply to abnormal vascular structures, these devices help to prevent bleeding, reduce pressure, and treat various neurological disorders. Using embolization devices is crucial for minimally invasive interventions, providing patients with effective treatment options while minimizing surgical risks and recovery times.

MARKET DYNAMICS

The embolization devices for neurology market is experiencing growth attributed to the increasing prevalence of neurological conditions requiring embolization, such as brain aneurysms and arteriovenous malformations (AVMs). As the incidence of these conditions rises, driven by factors such as aging populations & enhanced diagnostic capabilities, the demand for effective embolization treatments grows. Technological advancements are creating significant opportunities in the market. Innovations in embolization device materials and designs, such as the development of more biocompatible and flexible materials, are enhancing the safety and efficacy of treatments. The integration of advanced imaging technologies with embolization devices enables more precise and controlled procedures, improving patient outcomes.

The growing trend towards minimally invasive procedures also drives the growth of embolization devices for the neurology market. Embolization techniques offer less invasive alternatives to traditional surgical approaches, leading to shorter recovery times and reduced risk of complications. This shift towards less invasive treatments aligns with the increasing preference for procedures that minimize patient discomfort and recovery time. Additionally, expanding healthcare infrastructure and increasing investment in neurology and interventional radiology in emerging markets offer substantial growth opportunities. As healthcare systems in these areas progress, the adoption of advanced embolization devices is expected to rise, driven by improved access to specialized treatments and growing awareness of neurological conditions. However, high costs and procedural risks can cause embolization devices for neurology to restrain market growth. The significant expense of advanced embolization devices and the potential for complications during procedures may limit widespread adoption, particularly in cost-sensitive or resource-constrained healthcare settings.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Embolization Devices For Neurology. The growth and trends of Embolization Devices For Neurology industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Embolization Devices For Neurology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Embolization Coils
• Liquid Embolic Systems
• Flow Diversion Stents
• Aneurysm Clips
• Others

By Treatment

• Ischemic Stroke Solutions
• Hemorrhagic Stroke Solutions

By Indication

• Brain Aneurysms
• Arteriovenous Malformation (AVM)
• Others

By End User

• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Embolization Devices For Neurology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Embolization Devices For Neurology market include DePuy Synthes (Johnson & Johnson Services Inc.), Terumo Medical Corporation, Stryker Corporation, Boston Scientific Corporation, Penumbra Inc., Acandis GmbH, Balt Extrusion, Spartan Micro Inc., B. Braun Melsungen AG. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. EMBOLIZATION DEVICES FOR NEUROLOGY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Treatment
  • 3.7.3 Market Attractiveness Analysis By Indication
  • 3.7.4 Market Attractiveness Analysis By End User
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data Analysis By Product
• 5.3. Embolization Coils Historic and Forecast Sales By Regions
• 5.4. Liquid Embolic Systems Historic and Forecast Sales By Regions
• 5.5. Flow Diversion Stents Historic and Forecast Sales By Regions
• 5.6. Aneurysm Clips Historic and Forecast Sales By Regions
• 5.7. Others Historic and Forecast Sales By Regions

6. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY TREATMENT

• 6.1. Overview By Treatment
• 6.2. Historical and Forecast Data Analysis By Treatment
• 6.3. Ischemic Stroke Solutions Historic and Forecast Sales By Regions
• 6.4. Hemorrhagic Stroke Solutions Historic and Forecast Sales By Regions

7. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY INDICATION

• 7.1. Overview By Indication
• 7.2. Historical and Forecast Data Analysis By Indication
• 7.3. Brain Aneurysms Historic and Forecast Sales By Regions
• 7.4. Arteriovenous Malformation (AVM) Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY END USER

• 8.1. Overview By End User
• 8.2. Historical and Forecast Data Analysis By End User
• 8.3. Hospitals Historic and Forecast Sales By Regions
• 8.4. Ambulatory Surgical Centers Historic and Forecast Sales By Regions
• 8.5. Specialty Clinics Historic and Forecast Sales By Regions

9. GLOBAL EMBOLIZATION DEVICES FOR NEUROLOGY MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE EMBOLIZATION DEVICES FOR NEUROLOGY COMPANIES

• 10.1. Embolization Devices For Neurology Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF EMBOLIZATION DEVICES FOR NEUROLOGY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. DePuy Synthes (Johnson & Johnson Services Inc.)
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Terumo Medical Corporation
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Stryker Corporation
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. Boston Scientific Corporation
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. Penumbra Inc.
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. Acandis GmbH
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. Balt Extrusion
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Spartan Micro Inc.
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. B. Braun Melsungen AG
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies